Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism S1P agonists(membrane bound transcription factor peptidase, site 1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H25F3N4O5 |
InChIKeyYBQLZPRLWZZECJ-OXQOHEQNSA-N |
CAS Registry1265321-97-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 20 Feb 2019 |